CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and related software solutions, today announced that it received clearance from the U.S. Food and Drug Administration (FDA) to market and sell the ZOLL E Series® with See-Thru CPR™ technology. ZOLL’s patented See-Thru CPR helps minimize interruptions in CPR—one of the key recommendations of the American Heart Association’s (AHA) Guidelines for Advanced Cardiac Life Support.
